Revisiting subcallosal cingulate deep brain stimulation for depression: Long-term safety and effectiveness outcomes from a pooled analysis of 172 implanted patients
Lyndahl Himes(Abbott (United Kingdom)), Patricio Riva‐Posse(Emory University), Mustafa M. Husain(The University of Texas Southwestern Medical Center), Martijn Figee(Circuit Therapeutics (United States)), Alon Y. Mogilner(NYU Langone Health), Helen S. Mayberg(Icahn School of Medicine at Mount Sinai), Konstantin V. Slavin(University of Illinois Chicago), Julie G. Pilitsis(University of Arizona), Devyani Nanduri(Abbott Fund), Sidney H. Kennedy(University of Toronto), Robert E. Gross(Rutgers, The State University of New Jersey), Paul E. Holtzheimer(Emory University), Clement Hamani(University Health Network), Yagna Pathak(Columbia University Irving Medical Center), Andrés M. Lozano(University of Toronto), Binith Cheeran(Abbott (United States)), Joseph S. Neimat, Nader Pouratian(University of California, Los Angeles), Peter Giacobbe(University of Toronto), Brian H. Kopell(Icahn School of Medicine at Mount Sinai)
Cited by 10
Related Papers
Deep Brain Stimulation for Treatment-Resistant Depression
|Neuron|2005|4.1k
Toward discovery science of human brain function
|Proceedings of the National Academy of Sciences|2010|3.1k
Resting-state connectivity biomarkers define neurophysiological subtypes of depression
|Nature Medicine|2016|2.2k